Cite

    Sommerer, C. et al. (2018). Five‐year outcomes in kidney transplant patients randomized to everolimus with cyclosporine withdrawal or low‐exposure cyclosporine versus standard therapy. American journal of transplantation. 18 (12), pp. 2965-2976. [Online].